Author

Timo Minssen

Timo Minssen is Professor of Law at the University of Copenhagen (UCPH) and the Founder and Managing Director of UCPH’s Center for Advanced Studies in Biomedical Innovation Law (CeBIL). He is also affiliated with Lund University as a researcher in Quantum Law. His research concentrates on Intellectual Property, Competition & Regulatory Law with a special focus on new technologies in the pharma, life science & biotech sectors including biologics and biosimilars. His studies comprise a plethora of legal issues emerging in the lifecycle of biotechnological and medical products and processes – from the regulation of research and incentives for innovation to technology transfer and commercialization.
  • Bioethics

    A More Transparent System for Clinical Trials Data in Europe – Mind the Gaps!

    By Timo Minssen Following the approval of the European Parliament (EP) earlier last month, the Council of the European Union (the Council) adopted on 14 April 2014 a “Regulation on clinical trials on medicinal products…

    A More Transparent System for Clinical Trials Data in Europe – Mind the Gaps!

  • Biotechnology

    Review of Minssen, “Assessing the Inventiveness of Biopharmaceuticals under the European and U.S. Patent Laws”

    In “The “Problem” with the European Problem/Solution Approach to Inventive Step,” Harold C. Wegner reviews Petrie-Flom Visiting Scholar Timo Minssen‘s doctoral thesis. From the review: Patent applicants seeking to gain global patent protection beyond their…

    Review of Minssen, “Assessing the Inventiveness of Biopharmaceuticals under the European and U.S. Patent Laws”

  • Biotechnology

    Book Review published on SSRN

    By Timo Minssen Three weeks ago I blogged about my recent review of  “Pharmaceutical Innovation, Competition and Patent Law – a Trilateral Perspective” (Edward Elgar 2013). The full review, which is forthcoming in a spring issue of European…

    Book Review published on SSRN

  • Bioethics

    New paper on “Standardization, IPRs and Open Innovation in Synthetic Biology”

    By Timo Minssen I am pleased to announce that we have today published the following paper: Minssen, Timo and Wested, Jakob Blak, Standardization, IPRs and Open Innovation in Synthetic Biology (February 14, 2014). Available at…

    New paper on “Standardization, IPRs and Open Innovation in Synthetic Biology”

  • Generic Drugs

    Speech at US Patent Experts Conference in Naples Florida

    The University of Akron School of Law will host the 2nd Annual Midwinter Patent Experts Conference in Naples, Florida February 10-11, 2014. The conference will be held at the Naples Hilton Hotel. The faculty for…

    Speech at US Patent Experts Conference in Naples Florida

  • Biotechnology

    Book Review: Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective

    By Timo Minssen Following a request by the European Competition Law Review (Sweet Maxwell), I have today submitted a review of the recent publication  “Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective”, edited…

    Book Review: Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective

  • Uncategorized

    Call for abstracts: “Analyzing the societal dimensions of synthetic biology” summer school

    By Timo Minssen The Europäische Akademie GmbH – a research institution of the Federal State of Rhineland-Palatinate and the German Aerospace Center (DLR) – is currently inviting applications for the international summer school: “Analyzing the…

    Call for abstracts: “Analyzing the societal dimensions of synthetic biology” summer school